Double-blind Cross-over Study of Ketoprofen and Ibuprofen in Management of Rheumatoid ArthritisBr Med J 1973; 4 doi: https://doi.org/10.1136/bmj.4.5884.82 (Published 13 October 1973) Cite this as: Br Med J 1973;4:82
- Sarah B. Mills,
- M. Bloch,
- F. E. Bruckner
A double-blind cross-over study of ketoprofen (Orudis) 150 mg daily and ibuprofen (Brufen) 1,200 mg daily was carried out in 35 outpatients with rheumatoid arthritis. Results suggest that analgesic and anti-inflammatory activity of ketoprofen is superior to that of ibuprofen. Significantly greater pain relief (P < 0·05) and reduction in joint circumference (P < 0·01) was obtained with ketoprofen than with ibuprofen. Side effects of the drugs were comparable and not serious.